MedPath

SOMA

These highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) Tablets for Oral use Initial U.S. Approval: 1959

Approved
Approval ID

b38e1880-9152-4ca4-93e3-b9f6d14db958

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 7, 2011

Manufacturers
FDA

STAT RX USA LLC

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CARISOPRODOL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-755
Application NumberNDA011792
Product Classification
M
Marketing Category
C73594
G
Generic Name
CARISOPRODOL
Product Specifications
Route of AdministrationORAL
Effective DateJuly 7, 2011
FDA Product Classification

INGREDIENTS (5)

alginic acidInactive
Code: 8C3Z4148WZ
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
CARISOPRODOLActive
Quantity: 250 mg in 1 1
Code: 21925K482H
Classification: ACTIB
potassium sorbateInactive
Code: 1VPU26JZZ4
Classification: IACT
tribasic calcium phosphateInactive
Code: 91D9GV0Z28
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SOMA - FDA Drug Approval Details